Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

BACKGROUND: The risk of venous thromboembolic events (VTE) during adjuvant chemotherapy for colorectal cancer (CRC) is unknown. We aim to evaluate if the Khorana score (KS) can predict this risk, and if it represents a prognostic factor for overall survival (OS) through a post hoc analysis of the ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Barni, Sandro, Rosati, Gerardo, Lonardi, Sara, Pella, Nicoletta, Banzi, Maria, Zampino, Maria G., Dotti, Katia F., Rimassa, Lorenza, Marchetti, Paolo, Maiello, Evaristo, Artioli, Fabrizio, Ferrari, Daris, Labianca, Roberto, Bidoli, Paolo, Zaniboni, Alberto, Sobrero, Alberto, Iaffaioli, Vincenzo, De Placido, Sabino, Frassineti, Gian Luca, Ciarlo, Andrea, Buonadonna, Angela, Silvestris, Nicola, Piazza, Elena, Pavesi, Lorenzo, Moroni, Mauro, Clerico, Mario, Aglietta, Massimo, Giordani, Paolo, Galli, Francesca, Galli, Fabio, Petrelli, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974756/
https://www.ncbi.nlm.nih.gov/pubmed/32010236
http://dx.doi.org/10.1177/1758835919899850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974756/
https://www.ncbi.nlm.nih.gov/pubmed/32010236
http://dx.doi.org/10.1177/1758835919899850

Ejemplares similares